A Case of Refractory Bullous Pemphigoid Complicated by Atopic Dermatitis Successfully Treated with Dupilumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Case of Refractory Bullous Pemphigoid Complicated by Atopic Dermatitis Successfully Treated with Dupilumab

Published:2024-02-01 Issue:1 Volume:86 Page:26-29
ISSN:0386-9784
Container-title:The Nishinihon Journal of Dermatology
language:en
Short-container-title:Nishinihon J Dermatol

Author:

DAA Yamato¹,KOMORI Tamaki¹,KAWAKAMI Kaori¹,YASUNO Syuichiro¹,HISAMOTO Takafumi²,TAKAHATA Hiroaki²,SHIMOMURA Yutaka¹

Affiliation:

1. Department of Dermatology, Yamaguchi University Graduate School of Medicine

2. Department of Dermatology, Yamaguchi Red Cross Hospital

Publisher

Western Japan Division of JDA

Link

https://www.jstage.jst.go.jp/article/nishinihonhifu/86/1/86_26/_pdf

Reference8 articles.

1. 1) 氏家英之, 岩田浩明, 山上　淳ほか：類天疱瘡 (後天性表皮水疱症を含む) 診療ガイドライン. 日皮会誌, 2017；127：1483-1521.

2. 2) Liu Z, Giudice GJ, Swartz SJ et al : The role of complement in experimental bullous pemphigoid, J Clin Invest, 1995 ; 95 : 1539-1544.

3. 3) Ujiie H, Sasaoka T, Izumi K et al : Bullous pemphigoid autoantibodies directly induce blister formation without complement activation. J Immunol, 2014 ; 193 : 4415-4428.

4. 4) Teraki Y, Hotta T, Shiohara T : Skin-Homing Interleukin-4 and -13-Producing Cells Contribute to Bullous Pemphigoid : Remission of Disease is Associated with Increased Frequency of Interleukin-10-Producing Cells. J Invest Dermatol, 2001 ; 117 : 1097-1102.

5. 5) Takamura S, Teraki Y : Treatment of bullous pemphigoid with dupilumab : Dupilumab exerts its effect by primarily suppressing T-helper 2 cytokines. J Dermatol, 2022 ; 49 : 845-850.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP